An open-label, single-center, fixed-sequence study to investigate the pharmacokinetic drug-drug interaction potential of Omecamtiv mecarbil when co-administered with metformin in healthy subjects
Latest Information Update: 15 Jun 2021
At a glance
- Drugs Omecamtiv mecarbil (Primary) ; Metformin
- Indications Heart failure
- Focus Adverse reactions; Pharmacokinetics
- 15 Jun 2021 New trial record
- 07 Jun 2021 Results published in the Clinical Drug Investigation